涵盖百万“抗癌神针”！蚂蚁保旗下好医保可报国内全部CART疗法

快科技官方2025-06-24

快科技6月24日消息，近日，蚂蚁保旗下医疗险品牌“好医保”官宣升级，成为医疗保障领域的一大亮点。据介绍，核心三款产品升级后将国内批准上市的全部6种CAR-T疗法均纳入其先进药械报销清单。据悉，CAR-T细胞疗法是一种通过基因改造患者自身免疫细胞来精准识别并攻击癌细胞的新型免疫疗法，被广大网友称为“抗癌神针”。此前，该药也因为“一针一套房”的百万元级别定价，被病友群体熟知。目前该疗法尚未...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2545409764?lang=zh_CN&edition=full","thumbnail":"https://k.sinaimg.cn/n/spider20250624/643/w518h925/20250624/0fa1-c5e7632d819ce9a29810ab40ea2ddf0f.png/w120h90l50t1371.jpg","is_english":false,"pubTime":"2025-06-24 11:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545409764","market":"us","top_or_hot":-1,"title":"涵盖百万“抗癌神针”！蚂蚁保旗下好医保可报国内全部CART疗法","media":"快科技官方","content":"<div>\n<p>快科技6月24日消息，近日，蚂蚁保旗下医疗险品牌“好医保”官宣升级，成为医疗保障领域的一大亮点。据介绍，核心三款产品升级后将国内批准上市的全部6种CAR-T疗法均纳入其先进药械报销清单。据悉，CAR-T细胞疗法是一种通过基因改造患者自身免疫细胞来精准识别并攻击癌细胞的新型免疫疗法，被广大网友称为“抗癌神针”。此前，该药也因为“一针一套房”的百万元级别定价，被病友群体熟知。\n\n\n\n\n目前该疗法尚未...</p>\n\n<a href=\"https://tech.sina.cn/mobile/xp/2025-06-24/detail-infccywt5685095.d.html?vt=4\">网页链接</a>\n\n</div>\n","source":"sina_tech","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>涵盖百万“抗癌神针”！蚂蚁保旗下好医保可报国内全部CART疗法</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n涵盖百万“抗癌神针”！蚂蚁保旗下好医保可报国内全部CART疗法\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-24 11:41 北京时间&nbsp;&nbsp;&nbsp;<a href=https://tech.sina.cn/mobile/xp/2025-06-24/detail-infccywt5685095.d.html?vt=4><strong>快科技官方</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>快科技6月24日消息，近日，蚂蚁保旗下医疗险品牌“好医保”官宣升级，成为医疗保障领域的一大亮点。据介绍，核心三款产品升级后将国内批准上市的全部6种CAR-T疗法均纳入其先进药械报销清单。据悉，CAR-T细胞疗法是一种通过基因改造患者自身免疫细胞来精准识别并攻击癌细胞的新型免疫疗法，被广大网友称为“抗癌神针”。此前，该药也因为“一针一套房”的百万元级别定价，被病友群体熟知。\n\n\n\n\n目前该疗法尚未...</p>\n\n<a href=\"https://tech.sina.cn/mobile/xp/2025-06-24/detail-infccywt5685095.d.html?vt=4\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4113","symbol_name":"食品零售","start_time":0,"source_url":"https://tech.sina.cn/mobile/xp/2025-06-24/detail-infccywt5685095.d.html?vt=4","article_id":"2545409764","we_media_id":null,"thumbnails":["https://k.sinaimg.cn/n/spider20250624/643/w518h925/20250624/0fa1-c5e7632d819ce9a29810ab40ea2ddf0f.png/w120h90l50t1371.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2025-06-24/detail-infccywt5685095.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545409764","pubTimestamp":1750736464,"columns":[],"sourceInfo":{"source_id":"sina_tech","name":"新浪科技"},"weMediaInfo":null,"summary":"快科技6月24日消息，近日，蚂蚁保旗下医疗险品牌“好医保”官宣升级，成为医疗保障领域的一大亮点。据介绍，核心三款产品升级后将国内批准上市的全部6种CAR-T疗法均纳入其先进药械报销清单。据悉，CAR-T细胞疗法是一种通过基因改造患者自身免疫细胞来精准识别并攻击癌细胞的新型免疫疗法，被广大网友称为“抗癌神针”。此次好医保2025新版升级后，可报销的先进药械清单囊括国内批准的全部CAR-T疗法，这也体现了发展商业医疗险的补充价值。","collect":0,"end_time":0,"defaultTopTitle":"sina.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4113":"食品零售","BK4585":"ETF&股票定投概念","CART":"Instacart, Inc. (Maplebear Inc.)","BK4588":"碎股"},"translate_title":"Covering millions of \"anti-cancer magic needles\"! Good Medical Insurance, a subsidiary of Ant Insurance, can report for all CART therapies in China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CART":1},"content_text":"快科技6月24日消息，近日，蚂蚁保旗下医疗险品牌“好医保”官宣升级，成为医疗保障领域的一大亮点。据介绍，核心三款产品升级后将国内批准上市的全部6种CAR-T疗法均纳入其先进药械报销清单。据悉，CAR-T细胞疗法是一种通过基因改造患者自身免疫细胞来精准识别并攻击癌细胞的新型免疫疗法，被广大网友称为“抗癌神针”。此前，该药也因为“一针一套房”的百万元级别定价，被病友群体熟知。\n\n\n\n\n目前该疗法尚未进入我国医保目录，如需使用该疗法，患者需要自费承担。此次好医保2025新版升级后，可报销的先进药械清单囊括国内批准的全部CAR-T疗法，这也体现了发展商业医疗险的补充价值。有网友对此评论：“说实话，谁都不希望用上这些药，但真遇到大病时，能不能多一个选择，就特别重要。好医保这次升级让能治和敢治之间不再隔着一大笔钱。”【本文结束】如需转载请务必注明出处：快科技责任编辑：哈尔","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2545409764","isCrawlerRequest":true}